Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease. - Wikidata - thesis-toulmin - TriplyDB

Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.

Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.

http://www.wikidata.org/entity/Q34022803

about

Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients Quality of life in adolescent and young adult cancer patients: a systematic review of the literature Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation.Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells Quality of Life in the Chronic GVHD Consortium Cohort: Lessons Learned and the Long Road Ahead.The Role of Age in Neurocognitive Functioning among Adult Allogeneic Hematopoietic Cell Transplant Recipients.Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial.Determination of the psychiatric symptoms and psychological resilience levels of hematopoietic stem cell transplant patients and their relatives.Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Translation and validation of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) version 4 quality of life instrument into Arabic language.Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia.

P2860

Q26787230-6F2AA499-3D78-4D4A-B9DD-D87223DE455F Q35111293-656572DE-5A04-47BA-A777-362E735B7271 Q35155004-E8B5A037-396A-4351-AA7E-9C8BE598985E Q37015691-68BBC0F0-1593-4EC0-9278-6580A46A8227 Q38573015-51F250E9-8835-4274-A492-4FF327D1AB73 Q38629963-EA841532-6B13-49C6-8B87-D99F6872481A Q38829497-2994DD47-3051-478E-9AE4-7B4F94143662 Q39266886-C6BD2354-FD23-4A06-997B-319C891D7B59 Q50927701-6469483A-12B9-4440-A301-443D18BD9820 Q52660194-B67A940C-0214-49B4-933C-B6A75C97B764 Q55515367-161E886D-A1FF-43C5-8A4C-38D9FE3661DB

P2860

Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.

http://www.wikidata.org/entity/Q34022803

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Impact of age on quality of li ...... nic graft-versus-host disease.

@ast

Impact of age on quality of li ...... nic graft-versus-host disease.

@en

Impact of age on quality of li ...... nic graft-versus-host disease.

@nl

type

label

Impact of age on quality of li ...... nic graft-versus-host disease.

@ast

Impact of age on quality of li ...... nic graft-versus-host disease.

@en

Impact of age on quality of li ...... nic graft-versus-host disease.

@nl

prefLabel

Impact of age on quality of li ...... nic graft-versus-host disease.

@ast

Impact of age on quality of li ...... nic graft-versus-host disease.

@en

Impact of age on quality of li ...... nic graft-versus-host disease.

@nl

P1433

Q34022803-5046DBA1-DC5F-4A8D-8F8F-DA83FCF0EE5E

P1476

Q34022803-53E3F93C-08AA-40C7-AAAA-E58B21FE0DAA

P2093

Q34022803-0E8AC628-6A15-4392-9C05-CD15D0F97AD3

Q34022803-1169D111-1BDA-4353-B460-100AAA326A65

Q34022803-15501E9D-BA68-48C8-A9B6-4F692EB9715A

Q34022803-16A9F91A-F885-43E5-B7ED-A9CF283793A4

Q34022803-228BE7E3-0682-405A-BD19-9C8388D64BB6

Q34022803-3079DDEA-50DA-41C0-A2CC-71EC9075D2D6

Q34022803-315FDB42-FBAF-4B2C-886F-FA98743AA11E

Q34022803-43AA361F-8DD3-4B68-9AE1-DA768E6F5013

Q34022803-4A1D8089-2E2D-4646-ADBD-6710A87DBE69

Q34022803-4B330C02-A23D-4EBE-B0FF-BBFDACCDA31B

P2860

Q34022803-05440090-45BB-4F34-8126-390FDF5E7713

Q34022803-0E7891AC-AF4D-4A19-BA71-A3DD80FEB625

Q34022803-22BBC0BC-8274-4DEF-8FFF-C94017033799

Q34022803-3B74F49D-6C59-42B1-86F7-A11C887B9E21

Q34022803-3FBA6E48-D419-406F-9CD1-9BECDDB548E5

Q34022803-4161C184-FE87-4FEF-BC09-E0D2A3605FCF

Q34022803-4B16D174-F96C-4B4F-A2A2-5EA390B948D7

Q34022803-54623DAD-C195-4182-B8BC-7689482A778D

Q34022803-55CD2B93-6717-49E1-B6EA-29FECF808F8C

Q34022803-62DCC7A7-A49E-4368-BE93-E6190D92B14C

P304

Q34022803-58C4687F-F507-4444-B143-9AB7AC1447A0

P31

Q34022803-E89BF29F-FB97-42BA-A0BB-FC00CC69DF23

P356

Q34022803-500D55F6-9110-4407-84C1-4C098AEA9047

P433

Q34022803-BE6388ED-5554-4A1B-8635-05CC47F3B6DA

P478

Q34022803-5D730BB4-936C-4A3E-98E8-BF78E934E249

P50

Q34022803-5BF8822A-F14D-46C5-B24A-B99ECAA4D009

Q34022803-70D690DC-10AD-42E2-9B70-3AEF5FF2DAD9

P577

Q34022803-AC4CADEC-6766-4D75-8800-847139762F92

P698

Q34022803-502F2363-B043-4431-A82F-FE0F8FE5E4A1

P921

Q34022803-39C867FF-FC84-4296-91E6-1CEC56CDD1FA

P932

Q34022803-DB4A5296-AC31-47DC-AFD8-5C844AEB0DA0

P356

J.BBMT.2014.05.001

P1433

Biology of Blood and Marrow Transplantation

P1476

Impact of age on quality of li ...... nic graft-versus-host disease.

@en

P2093

Areej El-Jawahri

http://www.w3.org/2001/XMLSchema#string

Corey Cutler

http://www.w3.org/2001/XMLSchema#string

Daniel Weisdorf

http://www.w3.org/2001/XMLSchema#string

Jeanne Palmer

http://www.w3.org/2001/XMLSchema#string

Joseph Pidala

http://www.w3.org/2001/XMLSchema#string

Madan Jagasia

http://www.w3.org/2001/XMLSchema#string

Mary Flowers

http://www.w3.org/2001/XMLSchema#string

Mukta Arora

http://www.w3.org/2001/XMLSchema#string

Nandita Khera

http://www.w3.org/2001/XMLSchema#string

Paul A Carpenter

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.

Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD

Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B.

Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment

Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

P304

1341-1348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2014.05.001

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Stephanie J Lee

P577

2014-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24813171

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

P932

4127362

http://www.w3.org/2001/XMLSchema#string